search
Back to results

Effect of Topical Application of Hypertonic Saline on Melanoma on Its Sizes and Number.

Primary Purpose

Melanoma (Skin)

Status
Not yet recruiting
Phase
Phase 2
Locations
Study Type
Interventional
Intervention
Sodium Chloride Granules
Water
Sponsored by
Rafik Batroussy
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Melanoma (Skin)

Eligibility Criteria

5 Years - 80 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Patients with clinically-confirmed Melanoma (any location and any stage) who have poorly responded to at least one cycle of conventional and standard therapy (Chemotherapy, Radiation or Drug therapy). Age 5 to 80 years old Life expectancy of at least 1 year Can understand and read English Lives in USA. Patient who do not meet the Inclusion Criteria but still wish to participate will be accepted as Observational participants, but their Melanoma measurements will be not be taken into account when analyzing the Study statistically. Exclusion Criteria: Skin eczema and/or other skin conditions contraindicated to skin dehydration. Ulcers or open wounds close to Melanoma Any medical condition that might cause the patient to lose consciousness Participants who are not residents of USA.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Placebo Comparator

    Arm Label

    Active Group - Sodium Chloride Crystal Topical

    Control Group - Plain Water topical application

    Arm Description

    Each patient of the Active group will have their Melanoma covered by 2 drops of water, followed by applying Sodium Chloride granules to saturate the melanoma surface then add 2 more drops of water, then cover the NaCl-granules-covered Melanoma with a bandage. The bandage will stay in place for 12 hours daily and the procedure will be repeated daily for a total of 7 consecutive days, in addition to their standard treatments they receive from their health care providers, if any.

    Each patient of the Control group will have their Melanoma covered by 4 drops of water, then covered by a bandage. The bandage will stay in place for 12 hours daily and the procedure will be repeated daily for a total of 7 consecutive days, in addition to their standard treatments they receive from their health care providers, if any.

    Outcomes

    Primary Outcome Measures

    Melanoma size
    Change in Melanoma's parameters such as length and width.
    Melanoma number
    Change in Melanoma number

    Secondary Outcome Measures

    Full Information

    First Posted
    April 23, 2023
    Last Updated
    May 2, 2023
    Sponsor
    Rafik Batroussy
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05854589
    Brief Title
    Effect of Topical Application of Hypertonic Saline on Melanoma on Its Sizes and Number.
    Official Title
    Effect of Topical Application of Hypertonic Saline on Melanoma on Its Sizes and Number.
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    May 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    August 1, 2023 (Anticipated)
    Primary Completion Date
    February 29, 2024 (Anticipated)
    Study Completion Date
    June 30, 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor-Investigator
    Name of the Sponsor
    Rafik Batroussy

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Product Manufactured in and Exported from the U.S.
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    This study evaluates the effectiveness of applying Hypertonic Saline solution directly on the Melanomas in reducing their sizes and/or number.
    Detailed Description
    Many previous studies have shown that Cancer cells are over-hydrated, and that Hyponatraemia exists in many cases of Cancer. The Cancer cell's viability depends on Angiogenesis and formation of blood vessels that carry water and nutrients to the rapidly-dividing Cancer cells. This study tests the hypothesis that reducing the water content of Melanoma could lead to increasing its tonicity and hence inhibiting its growth. This reduction of water content can be achieved using Osmotic Pressure differential via applying highly saline solution - made by Sodium Chloride crystals wet with water - directly on the Melanoma for a certain amount of time, thus leading to water withdrawal from Melanoma cells. While the surrounding healthy skin cells can sustain temporary dehydration, Melanoma cells could be negatively affected.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Melanoma (Skin)

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 2
    Interventional Study Model
    Parallel Assignment
    Model Description
    A pilot randomized controlled study, whereas a number of patients with clinically-diagnosed skin Melanoma (any location and any stage), and who were poorly responsive to at least one cycle of conventional and standard therapy, are equally divided into 2 groups, Active and Control groups. Each patient of the Active group will have their Melanoma covered by 2 drops of water, followed by applying Sodium Chloride granules to saturate the melanoma surface then add 2 more drops of water, then cover the NaCl-granules-covered Melanoma with a bandage. The bandage will stay in place for 12 hours daily and the procedure will be repeated daily for a total of 7 consecutive days, in addition to their standard treatments they receive from their health care providers, if any. Each patient of the Control group will undergo the same treatment as the Active group patients minus the Sodium Chloride granules.
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    20 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Active Group - Sodium Chloride Crystal Topical
    Arm Type
    Active Comparator
    Arm Description
    Each patient of the Active group will have their Melanoma covered by 2 drops of water, followed by applying Sodium Chloride granules to saturate the melanoma surface then add 2 more drops of water, then cover the NaCl-granules-covered Melanoma with a bandage. The bandage will stay in place for 12 hours daily and the procedure will be repeated daily for a total of 7 consecutive days, in addition to their standard treatments they receive from their health care providers, if any.
    Arm Title
    Control Group - Plain Water topical application
    Arm Type
    Placebo Comparator
    Arm Description
    Each patient of the Control group will have their Melanoma covered by 4 drops of water, then covered by a bandage. The bandage will stay in place for 12 hours daily and the procedure will be repeated daily for a total of 7 consecutive days, in addition to their standard treatments they receive from their health care providers, if any.
    Intervention Type
    Drug
    Intervention Name(s)
    Sodium Chloride Granules
    Intervention Description
    Sodium Chloride crystals
    Intervention Type
    Other
    Intervention Name(s)
    Water
    Intervention Description
    Plain distilled water
    Primary Outcome Measure Information:
    Title
    Melanoma size
    Description
    Change in Melanoma's parameters such as length and width.
    Time Frame
    6 month
    Title
    Melanoma number
    Description
    Change in Melanoma number
    Time Frame
    6 month

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    5 Years
    Maximum Age & Unit of Time
    80 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patients with clinically-confirmed Melanoma (any location and any stage) who have poorly responded to at least one cycle of conventional and standard therapy (Chemotherapy, Radiation or Drug therapy). Age 5 to 80 years old Life expectancy of at least 1 year Can understand and read English Lives in USA. Patient who do not meet the Inclusion Criteria but still wish to participate will be accepted as Observational participants, but their Melanoma measurements will be not be taken into account when analyzing the Study statistically. Exclusion Criteria: Skin eczema and/or other skin conditions contraindicated to skin dehydration. Ulcers or open wounds close to Melanoma Any medical condition that might cause the patient to lose consciousness Participants who are not residents of USA.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Rafik Batroussy, BPharm
    Phone
    1-403-796-4441
    Email
    rafikbatroussy@hotmail.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Rafik Batroussy, BPharm
    Organizational Affiliation
    Independent Researcher
    Official's Role
    Study Chair

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    16271440
    Citation
    McIntyre GI. Cell hydration as the primary factor in carcinogenesis: A unifying concept. Med Hypotheses. 2006;66(3):518-26. doi: 10.1016/j.mehy.2005.09.022. Epub 2005 Nov 3.
    Results Reference
    background
    PubMed Identifier
    19799976
    Citation
    Machado M, Salgado TM, Hadgraft J, Lane ME. The relationship between transepidermal water loss and skin permeability. Int J Pharm. 2010 Jan 15;384(1-2):73-7. doi: 10.1016/j.ijpharm.2009.09.044. Epub 2009 Sep 30.
    Results Reference
    background
    Links:
    URL
    https://www.nature.com/articles/nchem.2021
    Description
    Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells.
    URL
    https://www.frontiersin.org/articles/10.3389/fimmu.2019.01141/full
    Description
    High Salt Inhibits Tumor Growth by Enhancing Anti-tumor Immunity.
    URL
    https://www.nature.com/articles/s41567-019-0680-8
    Description
    Cell swelling, softening and invasion in a three-dimensional breast cancer model.
    URL
    https://www.genengnews.com/news/cell-stiffness-may-indicate-likelihood-of-cancer-metastasis/
    Description
    Cell Stiffness May Indicate Likelihood of Cancer Metastasis.
    URL
    https://www.longdom.org/open-access/the-dysfunction-of-metabolic-controlling-of-cell-hydration-precedes-warburg-phenomenon-in-carcinogenesis-jbb.10000e59.pdf
    Description
    The Dysfunction of Metabolic Controlling of Cell Hydration Precedes Warburg Phenomenon in Carcinogenesis

    Learn more about this trial

    Effect of Topical Application of Hypertonic Saline on Melanoma on Its Sizes and Number.

    We'll reach out to this number within 24 hrs